Categories: Wire Stories

SORACOM Applies for Listing on the Tokyo Stock Exchange

TOKYO–(BUSINESS WIRE)–KDDI CORPORATION and SORACOM, INC, a global provider of advanced IoT connectivity services, today announced that SORACOM has applied to list its shares on the Tokyo Stock Exchange.

Soracom joined the KDDI Group in August 2017. Since then, Soracom has grown its IoT connectivity platform to support over 5 million IoT connections* for more than 20,000 customers worldwide in industries ranging from energy and manufacturing to payments, consumer electronics, healthcare, and agriculture .

From day one, Soracom has made its mission to deliver a global connectivity platform that accelerates speed to market for the teams building tomorrow�s connected world and helps them to pursue success at any scale.

To further accelerate its own business growth and global expansion, Soracom began preparation for a potential public offering in 2020. KDDI and SORACOM describe this as a “swing-by” IPO, in which a startup grows with the support of a larger company prior to public offering, as if a space probe accelerates using the gravitational mass of a planet. With appropriate corporate governance systems now in place and demonstrated capacity for independent management, Soracom has now applied to list its shares on the Tokyo Stock Exchange.

Prior to any such listing, it is necessary to obtain listing approval from the Tokyo Stock Exchange and complete examination by the Japan Exchange Regulation. This application does not establish any specific commitments regarding listing availability or timing.

Company Info

Company Name

SORACOM, INC.

Address

3F Ojima Building, 4-5-6 Tamagawa, Setagaya-ku, Tokyo, Japan

Name and Title of Representative

CEO Ken Tamagawa

Main Businesses

Providing the IoT platform “SORACOM”

Capital Stock

3,727 million yen (including capital reserve)

Date of Establishment

November 2014

* Total number of SORACOM Air connections including those provided by international entities, SORACOM Air for Cellular, Sigfox, and LoRaWAN.

This press release has been prepared for the sole purpose of publicly announcing that the Company has applied to list its shares on the Tokyo Stock Exchange, and not for the purpose of soliciting investment or engaging in any other similar activities within or outside Japan. This press release does not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States. Any securities may not be offered or sold in the United States absent registration or an exemption from registration under the U.S. Securities Act of 1933. If any public offering of securities is made in the United States, it will be made by means of an English language prospectus prepared in accordance with the U.S. Securities Act of 1933.

Contacts

SORACOM

info@soracom.io

Alex

Recent Posts

Getting Ready: LUX Helps Female Ex-Offenders Reintegrate Back to Society

LUX Launches ‘Getting Ready’ Campaign to Inspire Ex-offenders to Re-embrace Beauty and Re-enter Society with…

1 hour ago

PROTEINA Initiates Global Clinical Validation Project with Emory University School of Medicine, USA

SEOUL, South Korea--(BUSINESS WIRE)--#AcuteMyeloidLeukemia--PROTEINA announced today that it has held a kickoff meeting with Professor…

2 hours ago

Nordson Electronics Solutions Receives EM China Innovation Award for the New ASYMTEK Select Coat® SL-1040 Conformal Coating System

Recognized at the Productronica China tradeshow, the SL-1040 elevates coating performance with improved yield and…

4 hours ago

Hong Kong Ups the Game with New Incentive Playbook

Largest Celebration Ever with Over 110 Agents from Eight Markets to Experience Ultimate Hong Kong…

4 hours ago

DTEN’s Next Generation Video Conferencing and Collaboration Device for Zoom and Microsoft Teams, Now available in South Korea

DTEN’s Flagship D7X All-in-One Solution is Now KC and KCC Certified in South Korea, Delivering…

5 hours ago

AriBio Receives EMA Phase 3 Clinical Trial Authorisation for AR1001 in Treatment of Alzheimer’s Disease (POLARIS-AD)

SEONGNAM-SI, South Korea--(BUSINESS WIRE)--AriBio Co., Ltd. (AriBio) announced authorisation from the European Medicines Agency (EMA)…

6 hours ago